Oct-4: a prognostic biomarker of urinary bladder cancer in North India.

Zainab SiddiquiAnand N SrivastavaSatya N SankhwarNoorin ZaidiNaseem FatimaShivangi SinghMohd Yusuf

Published in: Therapeutic advances in urology (2019)

We conclude that the expression profile of Oct-4 will be beneficial in prediction of UBC recurrence, and could have profound implications on the development of new therapeutic targets for UBC treatment.

Keyphrases

optical coherence tomography
diabetic retinopathy
intellectual disability
tertiary care
free survival
autism spectrum disorder
combination therapy